Home

third generation vaccine, COVID-19 The road ahead Science, Safety and Immunogenicity of a DNA SARS-CoV-2 vaccine Results of an open-label, non-randomized I part of phase clinical study by intradermal route in healthy subjects India - eClinicalMedicine